A clinical laboratory-developed LSC17 stemness score assay for rapid risk assessment of patients with acute myeloid leukemia.
Ng SWK, Murphy T, King I, Zhang T, Mah M, Lu Z, Stickle N, Ibrahimova N, Arruda A, Mitchell A, Mai M, He R, Madala BS, Viswanatha DS, Dick JE, Chan S, Virtanen C, Minden MD, Mercer T, Stockley T, Wang JCY.
Ng SWK, et al. Among authors: minden md.
Blood Adv. 2022 Feb 8;6(3):1064-1073. doi: 10.1182/bloodadvances.2021005741.
Blood Adv. 2022.
PMID: 34872104
Free PMC article.